Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.63201667 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.31622606 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.07868076 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.07868076 |
5 | neutrophil activation involved in immune response (GO:0002283) | 4.85617255 |
6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.85531485 |
7 | detection of other organism (GO:0098543) | 4.79453435 |
8 | NIK/NF-kappaB signaling (GO:0038061) | 4.77517114 |
9 | detection of bacterium (GO:0016045) | 4.74397516 |
10 | negative thymic T cell selection (GO:0045060) | 4.67788499 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.57452916 |
12 | negative T cell selection (GO:0043383) | 4.52786998 |
13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.42014311 |
14 | macrophage activation involved in immune response (GO:0002281) | 4.22469836 |
15 | positive regulation of antigen processing and presentation (GO:0002579) | 4.18732043 |
16 | negative regulation of interleukin-12 production (GO:0032695) | 4.14189413 |
17 | immunoglobulin mediated immune response (GO:0016064) | 4.12522618 |
18 | neutrophil activation (GO:0042119) | 4.11802624 |
19 | myeloid dendritic cell activation (GO:0001773) | 4.10236765 |
20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.09574256 |
21 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.05164521 |
22 | myeloid dendritic cell differentiation (GO:0043011) | 4.01661554 |
23 | leukocyte aggregation (GO:0070486) | 3.97541609 |
24 | T cell migration (GO:0072678) | 3.96570555 |
25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.96133556 |
26 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.92033665 |
27 | cellular response to type I interferon (GO:0071357) | 3.91686599 |
28 | type I interferon signaling pathway (GO:0060337) | 3.91686599 |
29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.91239435 |
30 | regulation of B cell differentiation (GO:0045577) | 3.89555420 |
31 | response to type I interferon (GO:0034340) | 3.89063338 |
32 | granulocyte activation (GO:0036230) | 3.88173116 |
33 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.87586356 |
34 | detection of external biotic stimulus (GO:0098581) | 3.85644965 |
35 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.80179622 |
36 | cellular response to zinc ion (GO:0071294) | 3.73459657 |
37 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.73337825 |
38 | regulation of antigen processing and presentation (GO:0002577) | 3.69068482 |
39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.62758154 |
40 | regulation of T cell tolerance induction (GO:0002664) | 3.61808240 |
41 | response to peptidoglycan (GO:0032494) | 3.60861710 |
42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.57371946 |
43 | positive regulation of interleukin-12 production (GO:0032735) | 3.57311714 |
44 | B cell mediated immunity (GO:0019724) | 3.55474210 |
45 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.52953365 |
46 | regulation of mast cell degranulation (GO:0043304) | 3.52553987 |
47 | response to host immune response (GO:0052572) | 3.51068032 |
48 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.51068032 |
49 | positive regulation of interferon-alpha production (GO:0032727) | 3.43597013 |
50 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.42290855 |
51 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.42059547 |
52 | natural killer cell mediated immunity (GO:0002228) | 3.42059547 |
53 | thymic T cell selection (GO:0045061) | 3.41334774 |
54 | response to muramyl dipeptide (GO:0032495) | 3.40682675 |
55 | sequestering of actin monomers (GO:0042989) | 3.40489286 |
56 | positive regulation of B cell differentiation (GO:0045579) | 3.40008951 |
57 | respiratory burst (GO:0045730) | 3.38949497 |
58 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.38312363 |
59 | regulation of hypersensitivity (GO:0002883) | 3.37582344 |
60 | detection of biotic stimulus (GO:0009595) | 3.37373564 |
61 | defense response to protozoan (GO:0042832) | 3.36503634 |
62 | positive regulation of interleukin-2 production (GO:0032743) | 3.36495698 |
63 | cellular response to interferon-beta (GO:0035458) | 3.36049996 |
64 | B cell receptor signaling pathway (GO:0050853) | 3.34499469 |
65 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.33892077 |
66 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.33564235 |
67 | negative regulation of cell killing (GO:0031342) | 3.33564235 |
68 | regulation of gamma-delta T cell activation (GO:0046643) | 3.30188017 |
69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29679196 |
70 | positive regulation of mast cell activation (GO:0033005) | 3.28084576 |
71 | positive T cell selection (GO:0043368) | 3.26815474 |
72 | positive thymic T cell selection (GO:0045059) | 3.26511724 |
73 | T-helper 1 type immune response (GO:0042088) | 3.26433098 |
74 | negative regulation of phagocytosis (GO:0050765) | 3.25485572 |
75 | dendritic cell differentiation (GO:0097028) | 3.25368961 |
76 | detection of molecule of bacterial origin (GO:0032490) | 3.24534197 |
77 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23480784 |
78 | response to host (GO:0075136) | 3.23480784 |
79 | response to host defenses (GO:0052200) | 3.23480784 |
80 | T cell selection (GO:0045058) | 3.23394139 |
81 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.23215565 |
82 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.23106630 |
83 | regulation of interferon-alpha production (GO:0032647) | 3.23061481 |
84 | cellular extravasation (GO:0045123) | 3.21835540 |
85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.21158975 |
86 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.20452820 |
87 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.20452820 |
88 | regulation of RIG-I signaling pathway (GO:0039535) | 3.19338661 |
89 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.18534028 |
90 | mast cell activation (GO:0045576) | 3.17287257 |
91 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.17100150 |
92 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.16967104 |
93 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.15410204 |
94 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.14621919 |
95 | regulation of interleukin-12 production (GO:0032655) | 3.14351089 |
96 | leukocyte degranulation (GO:0043299) | 3.13970383 |
97 | tolerance induction (GO:0002507) | 3.12820122 |
98 | response to protozoan (GO:0001562) | 3.12305671 |
99 | regulation of mast cell activation (GO:0033003) | 3.12265397 |
100 | cellular response to interleukin-15 (GO:0071350) | 3.11951191 |
101 | germinal center formation (GO:0002467) | 3.11618643 |
102 | microglial cell activation (GO:0001774) | 3.10856843 |
103 | natural killer cell activation (GO:0030101) | 3.09398245 |
104 | interferon-gamma production (GO:0032609) | 3.08993029 |
105 | regulation of activation of Janus kinase activity (GO:0010533) | 3.08896607 |
106 | regulation of leukocyte degranulation (GO:0043300) | 3.08148455 |
107 | dendritic cell migration (GO:0036336) | 3.05397776 |
108 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.05374482 |
109 | cellular response to exogenous dsRNA (GO:0071360) | 3.03886847 |
110 | neutrophil mediated immunity (GO:0002446) | 3.03778160 |
111 | response to interferon-beta (GO:0035456) | 3.03656975 |
112 | dendritic cell chemotaxis (GO:0002407) | 3.03426081 |
113 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.02590745 |
114 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02462248 |
115 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.02436424 |
116 | natural killer cell differentiation (GO:0001779) | 3.01071291 |
117 | negative regulation of innate immune response (GO:0045824) | 2.99779523 |
118 | myeloid cell activation involved in immune response (GO:0002275) | 2.99479128 |
119 | positive regulation of humoral immune response (GO:0002922) | 2.99146319 |
120 | response to interleukin-15 (GO:0070672) | 2.98824120 |
121 | positive regulation of isotype switching (GO:0045830) | 2.97429378 |
122 | leukocyte mediated cytotoxicity (GO:0001909) | 2.97368648 |
123 | macrophage activation (GO:0042116) | 2.96883867 |
124 | mature B cell differentiation (GO:0002335) | 2.95832486 |
125 | lymphocyte mediated immunity (GO:0002449) | 2.94924418 |
126 | regulation of tolerance induction (GO:0002643) | 2.93543379 |
127 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.93094752 |
128 | positive regulation by symbiont of host defense response (GO:0052509) | 2.92961041 |
129 | modulation by symbiont of host defense response (GO:0052031) | 2.92961041 |
130 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.92961041 |
131 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.92961041 |
132 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.92961041 |
133 | modulation by symbiont of host immune response (GO:0052553) | 2.92961041 |
134 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.92798175 |
135 | T cell costimulation (GO:0031295) | 2.91656137 |
136 | positive regulation of macrophage differentiation (GO:0045651) | 2.91443445 |
137 | cellular response to interferon-gamma (GO:0071346) | 2.90936251 |
138 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.89987800 |
139 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89679388 |
140 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.86839364 |
141 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.86196682 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.61718027 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.68996672 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.42688493 |
4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.75785908 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.28283997 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.01495608 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82589760 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.67617319 |
9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.65042419 |
10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.49895243 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24957534 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.20493598 |
13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.11104327 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.96493132 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.87540786 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.75357428 |
17 | MYB_26560356_Chip-Seq_TH2_Human | 2.57614415 |
18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.52279084 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.51143988 |
20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.48309577 |
21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.42983020 |
22 | * MAF_26560356_Chip-Seq_TH1_Human | 2.40404384 |
23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30487354 |
24 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21496509 |
25 | MYB_26560356_Chip-Seq_TH1_Human | 2.18270289 |
26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16238305 |
27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.15762322 |
28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10788475 |
29 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.06451068 |
30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01841520 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99265141 |
32 | MYC_22102868_ChIP-Seq_BL_Human | 1.96025238 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92808045 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92593041 |
35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92053937 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.88991994 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83642045 |
38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74454629 |
39 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.67208482 |
40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.66684688 |
41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.64128009 |
42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64065829 |
43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63527435 |
44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57397153 |
45 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56199755 |
46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48831145 |
47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48527532 |
48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47103224 |
49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46881314 |
50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45868108 |
51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.44644722 |
52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44034099 |
53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42394397 |
54 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40051127 |
55 | * MAF_26560356_Chip-Seq_TH2_Human | 1.39316397 |
56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39298220 |
57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38721218 |
58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38369127 |
59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36790910 |
60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35770724 |
61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33764734 |
62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33336223 |
63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29508035 |
64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28617718 |
65 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25294851 |
66 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21164323 |
67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20401828 |
68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17737685 |
69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16941713 |
70 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16812466 |
71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16709779 |
72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16153552 |
73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09341162 |
74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08274000 |
75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07672893 |
76 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07573205 |
77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06073669 |
78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05911735 |
79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05314108 |
80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05034505 |
81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04771603 |
82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03688396 |
83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01319248 |
84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00947114 |
85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99714216 |
86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98160661 |
87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97798540 |
88 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.97296566 |
89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95058204 |
90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94733698 |
91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94710909 |
92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94591804 |
93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93328691 |
94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91875026 |
95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91576927 |
96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90498594 |
97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89532897 |
98 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.88031208 |
99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87630266 |
100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86248136 |
101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81595020 |
102 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.73897664 |
103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.73227945 |
104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72878713 |
105 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70150886 |
106 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.62677951 |
107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.62281196 |
108 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.61468147 |
109 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.61392279 |
110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.61245024 |
111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59414895 |
112 | P300_27268052_Chip-Seq_Bcells_Human | 0.57956099 |
113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.57638492 |
114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.56922633 |
115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.56743044 |
116 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56673032 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.64054958 |
2 | MP0005671_abnormal_response_to | 3.81106872 |
3 | * MP0000685_abnormal_immune_system | 3.71557582 |
4 | MP0009785_altered_susceptibility_to | 3.54766859 |
5 | MP0002148_abnormal_hypersensitivity_rea | 3.48712580 |
6 | MP0001790_abnormal_immune_system | 3.48550121 |
7 | MP0005387_immune_system_phenotype | 3.48550121 |
8 | MP0003436_decreased_susceptibility_to | 3.35474412 |
9 | MP0005000_abnormal_immune_tolerance | 3.17033938 |
10 | MP0001800_abnormal_humoral_immune | 3.13078864 |
11 | MP0002452_abnormal_antigen_presenting | 2.94714886 |
12 | MP0005025_abnormal_response_to | 2.93265712 |
13 | MP0002166_altered_tumor_susceptibility | 2.87105680 |
14 | MP0002723_abnormal_immune_serum | 2.80254099 |
15 | * MP0001819_abnormal_immune_cell | 2.70290623 |
16 | * MP0002420_abnormal_adaptive_immunity | 2.68398856 |
17 | * MP0002419_abnormal_innate_immunity | 2.67835762 |
18 | MP0004510_myositis | 2.65183476 |
19 | MP0002006_tumorigenesis | 2.52157967 |
20 | MP0003763_abnormal_thymus_physiology | 2.52142351 |
21 | MP0002138_abnormal_hepatobiliary_system | 2.43228523 |
22 | MP0006082_CNS_inflammation | 2.33372726 |
23 | * MP0002398_abnormal_bone_marrow | 2.22086697 |
24 | * MP0000716_abnormal_immune_system | 2.15163735 |
25 | MP0002405_respiratory_system_inflammati | 2.14375872 |
26 | MP0001853_heart_inflammation | 2.05121560 |
27 | MP0001348_abnormal_lacrimal_gland | 1.95356286 |
28 | MP0003303_peritoneal_inflammation | 1.94855420 |
29 | MP0003724_increased_susceptibility_to | 1.94308217 |
30 | MP0005310_abnormal_salivary_gland | 1.90650393 |
31 | MP0010155_abnormal_intestine_physiology | 1.82988662 |
32 | MP0005464_abnormal_platelet_physiology | 1.80823112 |
33 | MP0001845_abnormal_inflammatory_respons | 1.78946691 |
34 | MP0009333_abnormal_splenocyte_physiolog | 1.75916861 |
35 | MP0004947_skin_inflammation | 1.73623382 |
36 | MP0000689_abnormal_spleen_morphology | 1.73512332 |
37 | MP0001873_stomach_inflammation | 1.73360666 |
38 | * MP0002429_abnormal_blood_cell | 1.73343506 |
39 | MP0002722_abnormal_immune_system | 1.70655820 |
40 | MP0002396_abnormal_hematopoietic_system | 1.67034682 |
41 | MP0002163_abnormal_gland_morphology | 1.65444513 |
42 | MP0002009_preneoplasia | 1.61429939 |
43 | MP0005451_abnormal_body_composition | 1.50060939 |
44 | MP0001533_abnormal_skeleton_physiology | 1.50059045 |
45 | MP0002933_joint_inflammation | 1.48020051 |
46 | MP0008260_abnormal_autophagy | 1.45067579 |
47 | MP0008469_abnormal_protein_level | 1.41482447 |
48 | MP0003448_altered_tumor_morphology | 1.37075303 |
49 | MP0000703_abnormal_thymus_morphology | 1.36628051 |
50 | MP0000858_altered_metastatic_potential | 1.34205559 |
51 | MP0009764_decreased_sensitivity_to | 1.31121364 |
52 | MP0005397_hematopoietic_system_phenotyp | 1.27692972 |
53 | MP0001545_abnormal_hematopoietic_system | 1.27692972 |
54 | MP0004808_abnormal_hematopoietic_stem | 1.22902288 |
55 | MP0004381_abnormal_hair_follicle | 1.16635320 |
56 | MP0002254_reproductive_system_inflammat | 1.15728649 |
57 | MP0005058_abnormal_lysosome_morphology | 1.13618490 |
58 | MP0004883_abnormal_blood_vessel | 1.11068400 |
59 | MP0005174_abnormal_tail_pigmentation | 1.10833702 |
60 | MP0003300_gastrointestinal_ulcer | 1.08946768 |
61 | MP0003866_abnormal_defecation | 1.08722576 |
62 | MP0002998_abnormal_bone_remodeling | 1.08159851 |
63 | MP0009278_abnormal_bone_marrow | 1.02141727 |
64 | MP0003806_abnormal_nucleotide_metabolis | 0.94729553 |
65 | MP0005379_endocrine/exocrine_gland_phen | 0.93646892 |
66 | MP0002277_abnormal_respiratory_mucosa | 0.92380183 |
67 | MP0000604_amyloidosis | 0.92242278 |
68 | MP0000343_altered_response_to | 0.92041494 |
69 | MP0000569_abnormal_digit_pigmentation | 0.91655489 |
70 | MP0003690_abnormal_glial_cell | 0.90730806 |
71 | MP0005076_abnormal_cell_differentiation | 0.89455650 |
72 | MP0008057_abnormal_DNA_replication | 0.88582393 |
73 | MP0000490_abnormal_crypts_of | 0.88014786 |
74 | MP0005164_abnormal_response_to | 0.82559484 |
75 | MP0002877_abnormal_melanocyte_morpholog | 0.78727738 |
76 | MP0009840_abnormal_foam_cell | 0.78244716 |
77 | MP0002019_abnormal_tumor_incidence | 0.78097703 |
78 | MP0001346_abnormal_lacrimal_gland | 0.76846740 |
79 | MP0003828_pulmonary_edema | 0.76553835 |
80 | MP0003183_abnormal_peptide_metabolism | 0.76428114 |
81 | MP0000465_gastrointestinal_hemorrhage | 0.76084422 |
82 | MP0002132_abnormal_respiratory_system | 0.73991041 |
83 | MP0005390_skeleton_phenotype | 0.72991061 |
84 | MP0003075_altered_response_to | 0.71635239 |
85 | MP0009763_increased_sensitivity_to | 0.71468279 |
86 | MP0000249_abnormal_blood_vessel | 0.69888438 |
87 | MP0003172_abnormal_lysosome_physiology | 0.68676699 |
88 | MP0001986_abnormal_taste_sensitivity | 0.68167378 |
89 | MP0002876_abnormal_thyroid_physiology | 0.66356722 |
90 | MP0006054_spinal_hemorrhage | 0.65680518 |
91 | MP0009765_abnormal_xenobiotic_induced | 0.65371190 |
92 | MP0008004_abnormal_stomach_pH | 0.64931794 |
93 | MP0001851_eye_inflammation | 0.64925905 |
94 | MP0003191_abnormal_cellular_cholesterol | 0.64056977 |
95 | MP0008874_decreased_physiological_sensi | 0.62152706 |
96 | MP0010307_abnormal_tumor_latency | 0.61670909 |
97 | MP0005166_decreased_susceptibility_to | 0.58852580 |
98 | MP0000371_diluted_coat_color | 0.58040694 |
99 | MP0010352_gastrointestinal_tract_polyps | 0.57359279 |
100 | MP0003091_abnormal_cell_migration | 0.57317563 |
101 | MP0003656_abnormal_erythrocyte_physiolo | 0.56743575 |
102 | MP0003795_abnormal_bone_structure | 0.56248774 |
103 | MP0003045_fibrosis | 0.56136374 |
104 | MP0003453_abnormal_keratinocyte_physiol | 0.56112501 |
105 | MP0003566_abnormal_cell_adhesion | 0.55480042 |
106 | MP0002095_abnormal_skin_pigmentation | 0.55332194 |
107 | MP0000015_abnormal_ear_pigmentation | 0.55160670 |
108 | MP0002136_abnormal_kidney_physiology | 0.53667874 |
109 | MP0000767_abnormal_smooth_muscle | 0.52643293 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.52338565 |
111 | MP0002693_abnormal_pancreas_physiology | 0.51809990 |
112 | MP0008007_abnormal_cellular_replicative | 0.50237574 |
113 | MP0001243_abnormal_dermal_layer | 0.49267082 |
114 | MP0005075_abnormal_melanosome_morpholog | 0.47464434 |
115 | MP0001881_abnormal_mammary_gland | 0.45372623 |
116 | MP0000609_abnormal_liver_physiology | 0.45262074 |
117 | MP0001663_abnormal_digestive_system | 0.44942196 |
118 | MP0000920_abnormal_myelination | 0.44531154 |
119 | MP0004130_abnormal_muscle_cell | 0.43658651 |
120 | MP0005381_digestive/alimentary_phenotyp | 0.43215169 |
121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.38765576 |
122 | MP0005376_homeostasis/metabolism_phenot | 0.36477313 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.36941287 |
2 | Recurrent bacterial skin infections (HP:0005406) | 6.07364846 |
3 | Eczematoid dermatitis (HP:0000976) | 5.93714665 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.51072508 |
5 | Myositis (HP:0100614) | 5.17568194 |
6 | Retrobulbar optic neuritis (HP:0100654) | 4.65434922 |
7 | Optic neuritis (HP:0100653) | 4.65434922 |
8 | Recurrent fungal infections (HP:0002841) | 4.63354273 |
9 | Orchitis (HP:0100796) | 4.46471276 |
10 | Recurrent viral infections (HP:0004429) | 4.27997591 |
11 | Recurrent skin infections (HP:0001581) | 4.20736067 |
12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.17653228 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 4.11143448 |
14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.07317947 |
15 | Increased IgM level (HP:0003496) | 4.04677177 |
16 | Chronic otitis media (HP:0000389) | 3.94652903 |
17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.81602384 |
18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.81602384 |
19 | Abnormality of macrophages (HP:0004311) | 3.80608325 |
20 | Vasculitis (HP:0002633) | 3.79092846 |
21 | Autoimmune thrombocytopenia (HP:0001973) | 3.74249831 |
22 | Abnormality of T cell number (HP:0011839) | 3.69189952 |
23 | Agammaglobulinemia (HP:0004432) | 3.67429445 |
24 | Meningitis (HP:0001287) | 3.64837004 |
25 | Obstructive lung disease (HP:0006536) | 3.50792720 |
26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.50792720 |
27 | Gastrointestinal infarctions (HP:0005244) | 3.50230924 |
28 | Recurrent bronchitis (HP:0002837) | 3.47155445 |
29 | Thrombocytosis (HP:0001894) | 3.37671568 |
30 | Panhypogammaglobulinemia (HP:0003139) | 3.36109601 |
31 | Cellulitis (HP:0100658) | 3.32145664 |
32 | T lymphocytopenia (HP:0005403) | 3.22324264 |
33 | IgM deficiency (HP:0002850) | 3.19957742 |
34 | Pulmonary infiltrates (HP:0002113) | 3.17075196 |
35 | Abnormality of T cells (HP:0002843) | 3.14498131 |
36 | Keratoconjunctivitis sicca (HP:0001097) | 3.11347116 |
37 | Gingivitis (HP:0000230) | 3.10471811 |
38 | Arterial thrombosis (HP:0004420) | 3.07510351 |
39 | Leukocytosis (HP:0001974) | 3.02299495 |
40 | Hypergammaglobulinemia (HP:0010702) | 2.96035441 |
41 | Nasal polyposis (HP:0100582) | 2.95227547 |
42 | Stomatitis (HP:0010280) | 2.94227696 |
43 | Abnormality of T cell physiology (HP:0011840) | 2.94037584 |
44 | Prolonged bleeding time (HP:0003010) | 2.91541262 |
45 | Inflammation of the large intestine (HP:0002037) | 2.91251038 |
46 | Colitis (HP:0002583) | 2.91167333 |
47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.89783506 |
48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.89783506 |
49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.89783506 |
50 | Encephalitis (HP:0002383) | 2.87913967 |
51 | Keratoconjunctivitis (HP:0001096) | 2.86891269 |
52 | Eosinophilia (HP:0001880) | 2.85401112 |
53 | Hypochromic microcytic anemia (HP:0004840) | 2.81019643 |
54 | IgG deficiency (HP:0004315) | 2.79977440 |
55 | Hemoptysis (HP:0002105) | 2.79904594 |
56 | Gastrointestinal inflammation (HP:0004386) | 2.79776426 |
57 | Pustule (HP:0200039) | 2.79746051 |
58 | Thyroiditis (HP:0100646) | 2.75555549 |
59 | Hypochromic anemia (HP:0001931) | 2.74447435 |
60 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.69605842 |
61 | Interstitial pulmonary disease (HP:0006530) | 2.68180779 |
62 | Spontaneous hematomas (HP:0007420) | 2.66734755 |
63 | Abnormality of the nasal mucosa (HP:0000433) | 2.63950871 |
64 | Autoimmune hemolytic anemia (HP:0001890) | 2.62731778 |
65 | Abnormality of eosinophils (HP:0001879) | 2.59676971 |
66 | Severe combined immunodeficiency (HP:0004430) | 2.59159898 |
67 | Recurrent pneumonia (HP:0006532) | 2.58868192 |
68 | Lymphopenia (HP:0001888) | 2.56848670 |
69 | Episodic fever (HP:0001954) | 2.56435168 |
70 | Basal ganglia calcification (HP:0002135) | 2.54491419 |
71 | Granulocytopenia (HP:0001913) | 2.54094433 |
72 | Recurrent lower respiratory tract infections (HP:0002783) | 2.51578996 |
73 | Urticaria (HP:0001025) | 2.51200509 |
74 | Pulmonary embolism (HP:0002204) | 2.49601083 |
75 | Periodontitis (HP:0000704) | 2.49195388 |
76 | Combined immunodeficiency (HP:0005387) | 2.47967704 |
77 | Increased IgE level (HP:0003212) | 2.42254809 |
78 | Spinal cord lesions (HP:0100561) | 2.40347338 |
79 | Syringomyelia (HP:0003396) | 2.40347338 |
80 | Systemic lupus erythematosus (HP:0002725) | 2.39189507 |
81 | Anorexia (HP:0002039) | 2.39071151 |
82 | Purpura (HP:0000979) | 2.37455602 |
83 | Chest pain (HP:0100749) | 2.35628407 |
84 | Petechiae (HP:0000967) | 2.35014380 |
85 | Vacuolated lymphocytes (HP:0001922) | 2.32924779 |
86 | Chronic diarrhea (HP:0002028) | 2.31020731 |
87 | Gastrointestinal stroma tumor (HP:0100723) | 2.30169629 |
88 | Hepatosplenomegaly (HP:0001433) | 2.29975927 |
89 | Peritonitis (HP:0002586) | 2.29016882 |
90 | Verrucae (HP:0200043) | 2.26101561 |
91 | Papilloma (HP:0012740) | 2.26101561 |
92 | Osteomyelitis (HP:0002754) | 2.26080501 |
93 | Absent frontal sinuses (HP:0002688) | 2.25449618 |
94 | Gangrene (HP:0100758) | 2.24390273 |
95 | Hematochezia (HP:0002573) | 2.23901222 |
96 | Gingival bleeding (HP:0000225) | 2.20083631 |
97 | Amyloidosis (HP:0011034) | 2.19708602 |
98 | Fatigue (HP:0012378) | 2.18053605 |
99 | Chronic sinusitis (HP:0011109) | 2.17329814 |
100 | IgA deficiency (HP:0002720) | 2.16867535 |
101 | Loss of speech (HP:0002371) | 2.16480067 |
102 | Microcytic anemia (HP:0001935) | 2.15314161 |
103 | Emphysema (HP:0002097) | 2.15297565 |
104 | Joint swelling (HP:0001386) | 2.14890071 |
105 | Prostate neoplasm (HP:0100787) | 2.12932784 |
106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12266149 |
107 | Restrictive lung disease (HP:0002091) | 2.12238636 |
108 | Premature loss of primary teeth (HP:0006323) | 2.12014691 |
109 | Abnormality of the prostate (HP:0008775) | 2.11243395 |
110 | Dysostosis multiplex (HP:0000943) | 2.09562233 |
111 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.09373991 |
112 | Skin rash (HP:0000988) | 2.09043930 |
113 | Glomerulopathy (HP:0100820) | 2.06227456 |
114 | Skin ulcer (HP:0200042) | 2.05975075 |
115 | Recurrent sinusitis (HP:0011108) | 2.04722187 |
116 | Sepsis (HP:0100806) | 2.04632471 |
117 | Abnormality of the pleura (HP:0002103) | 2.03634354 |
118 | Abnormality of the peritoneum (HP:0002585) | 2.02045998 |
119 | Increased serum ferritin (HP:0003281) | 2.01348656 |
120 | Agnosia (HP:0010524) | 1.99235534 |
121 | Arthralgia (HP:0002829) | 1.98113400 |
122 | Increased cerebral lipofuscin (HP:0011813) | 1.97945183 |
123 | Epistaxis (HP:0000421) | 1.96018603 |
124 | Abnormality of the fingertips (HP:0001211) | 1.95526983 |
125 | Polyneuropathy (HP:0001271) | 1.94268097 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.43282751 |
2 | MAP3K14 | 4.39928114 |
3 | TYK2 | 3.39317932 |
4 | JAK3 | 3.37882477 |
5 | IRAK4 | 3.28431760 |
6 | TBK1 | 3.10969096 |
7 | IKBKB | 2.75388745 |
8 | BLK | 2.69909803 |
9 | TXK | 2.64545912 |
10 | IKBKE | 2.61564840 |
11 | PRPF4B | 2.41100284 |
12 | KIT | 2.35029172 |
13 | TNK2 | 2.27505710 |
14 | MAP3K13 | 2.26674301 |
15 | RIPK4 | 2.22520147 |
16 | ZAP70 | 2.16853293 |
17 | BTK | 2.06836380 |
18 | CSF1R | 2.05626609 |
19 | JAK1 | 2.03427354 |
20 | SYK | 1.93843346 |
21 | IRAK3 | 1.87700439 |
22 | CHUK | 1.81660287 |
23 | MAP3K11 | 1.80004263 |
24 | STK10 | 1.75773127 |
25 | FLT3 | 1.72047935 |
26 | TEC | 1.70287281 |
27 | PIM2 | 1.66679094 |
28 | CSK | 1.65160300 |
29 | TAOK1 | 1.50463858 |
30 | LCK | 1.41936105 |
31 | MAP3K3 | 1.39130019 |
32 | EPHB1 | 1.30444966 |
33 | ITK | 1.30344319 |
34 | FGFR4 | 1.28681086 |
35 | HCK | 1.28334487 |
36 | LRRK2 | 1.25315056 |
37 | PIM1 | 1.25029833 |
38 | NME2 | 1.24441121 |
39 | LYN | 1.20056475 |
40 | TAOK3 | 1.19905157 |
41 | NEK9 | 1.18686791 |
42 | FGFR3 | 1.11153218 |
43 | GRK6 | 1.09188127 |
44 | MST4 | 1.08467415 |
45 | MAP3K1 | 1.05894329 |
46 | NLK | 1.03882016 |
47 | KDR | 1.03089327 |
48 | RPS6KA4 | 1.02462973 |
49 | TAOK2 | 0.97697628 |
50 | CLK1 | 0.97058559 |
51 | FES | 0.92824819 |
52 | TGFBR2 | 0.91117801 |
53 | TESK2 | 0.88940408 |
54 | SMG1 | 0.88658493 |
55 | ERN1 | 0.85456826 |
56 | JAK2 | 0.83351762 |
57 | SIK3 | 0.83088885 |
58 | BMPR2 | 0.83053870 |
59 | PRKCQ | 0.82309371 |
60 | STK4 | 0.82189764 |
61 | MAP3K12 | 0.77008821 |
62 | PRKD2 | 0.76978108 |
63 | MAPK12 | 0.76130550 |
64 | KSR2 | 0.75703987 |
65 | MARK2 | 0.74947921 |
66 | STK24 | 0.69194625 |
67 | ACVR1B | 0.68787540 |
68 | GRK7 | 0.67770172 |
69 | CDC42BPA | 0.67623999 |
70 | MAP3K10 | 0.66866179 |
71 | FYN | 0.64456843 |
72 | CDK19 | 0.64213456 |
73 | MARK3 | 0.63745150 |
74 | MAP2K3 | 0.62106014 |
75 | PDPK1 | 0.61845822 |
76 | PRKCD | 0.60186274 |
77 | MAPK7 | 0.59537524 |
78 | PIK3CG | 0.59532036 |
79 | EPHA3 | 0.58174769 |
80 | TGFBR1 | 0.55967281 |
81 | TTN | 0.54806698 |
82 | FGR | 0.54574935 |
83 | CAMKK1 | 0.54041937 |
84 | TRPM7 | 0.53346130 |
85 | ABL1 | 0.53183458 |
86 | EIF2AK2 | 0.51534598 |
87 | HIPK2 | 0.51317589 |
88 | TRIB3 | 0.50873309 |
89 | TESK1 | 0.50567500 |
90 | IRAK2 | 0.49254391 |
91 | ARAF | 0.49127149 |
92 | MAP3K8 | 0.48866305 |
93 | MAP3K7 | 0.48694130 |
94 | IRAK1 | 0.47319460 |
95 | RPS6KA6 | 0.46632489 |
96 | SIK2 | 0.46197282 |
97 | ADRBK2 | 0.45015140 |
98 | MAP3K5 | 0.44164854 |
99 | * MAPKAPK2 | 0.41699226 |
100 | CAMKK2 | 0.41499639 |
101 | CDK9 | 0.40227051 |
102 | SIK1 | 0.37666699 |
103 | CDK4 | 0.37595440 |
104 | PTK6 | 0.36449582 |
105 | STK11 | 0.35153949 |
106 | MATK | 0.34950241 |
107 | MOS | 0.34740525 |
108 | RAF1 | 0.34293876 |
109 | YES1 | 0.34090134 |
110 | PRKCH | 0.33874940 |
111 | CDK6 | 0.33561718 |
112 | PKN1 | 0.32676485 |
113 | PTK2B | 0.32437960 |
114 | MAP3K6 | 0.31482689 |
115 | MAPK11 | 0.30529049 |
116 | DYRK1B | 0.30239514 |
117 | RPS6KC1 | 0.30057134 |
118 | RPS6KL1 | 0.30057134 |
119 | MAP2K2 | 0.29385914 |
120 | TLK1 | 0.28845629 |
121 | EGFR | 0.28420827 |
122 | RPS6KA5 | 0.25934439 |
123 | NUAK1 | 0.25704844 |
124 | MYLK | 0.25029397 |
125 | BMPR1B | 0.24558949 |
126 | BCKDK | 0.23629838 |
127 | PDK1 | 0.23174278 |
128 | MAPK4 | 0.22909386 |
129 | CDK12 | 0.22793016 |
130 | MAP2K6 | 0.22710251 |
131 | ABL2 | 0.22253324 |
132 | ILK | 0.21111395 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.51397598 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.29784822 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.23598967 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.06498929 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.91807246 |
6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.89732646 |
7 | Measles_Homo sapiens_hsa05162 | 2.54150753 |
8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.41633517 |
9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.36968822 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.28906254 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24798984 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22524983 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.15065466 |
14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.11288478 |
15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.09499850 |
16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96320060 |
17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.93632739 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.87202126 |
19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.81506384 |
20 | Legionellosis_Homo sapiens_hsa05134 | 1.77892497 |
21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.75671235 |
22 | Influenza A_Homo sapiens_hsa05164 | 1.70375768 |
23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69991690 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.69638922 |
25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.67441767 |
26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.65406127 |
27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65205896 |
28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.65200689 |
29 | Shigellosis_Homo sapiens_hsa05131 | 1.64778451 |
30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.60806472 |
31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.57159885 |
32 | Malaria_Homo sapiens_hsa05144 | 1.53526566 |
33 | * Tuberculosis_Homo sapiens_hsa05152 | 1.51765719 |
34 | Apoptosis_Homo sapiens_hsa04210 | 1.49845502 |
35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47526499 |
36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44128411 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36038290 |
38 | Salmonella infection_Homo sapiens_hsa05132 | 1.34995953 |
39 | Hepatitis B_Homo sapiens_hsa05161 | 1.22547692 |
40 | Asthma_Homo sapiens_hsa05310 | 1.21445023 |
41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20028968 |
42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18466174 |
43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10592251 |
44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10048040 |
45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07938756 |
46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.05956295 |
47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03749947 |
48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00305103 |
49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96402593 |
50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.94676107 |
51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88986287 |
52 | Hepatitis C_Homo sapiens_hsa05160 | 0.87188813 |
53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86492609 |
54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86209486 |
55 | Platelet activation_Homo sapiens_hsa04611 | 0.85049744 |
56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82353648 |
57 | Lysosome_Homo sapiens_hsa04142 | 0.79274038 |
58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70388840 |
59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69284284 |
60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68714265 |
61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68682067 |
62 | Phagosome_Homo sapiens_hsa04145 | 0.68086889 |
63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65695364 |
64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61479279 |
65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60854969 |
66 | Proteasome_Homo sapiens_hsa03050 | 0.59184952 |
67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57640567 |
68 | Base excision repair_Homo sapiens_hsa03410 | 0.54354180 |
69 | Ribosome_Homo sapiens_hsa03010 | 0.49417744 |
70 | DNA replication_Homo sapiens_hsa03030 | 0.49282189 |
71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49190094 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.44964663 |
73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44807997 |
74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44560826 |
75 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44153488 |
76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43920470 |
77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43908301 |
78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42812600 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42793798 |
80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41092852 |
81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37475981 |
82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36884284 |
83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32316467 |
84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31887702 |
85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31338552 |
86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30878892 |
87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30864202 |
88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30776016 |
89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30602710 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28774352 |
91 | Endocytosis_Homo sapiens_hsa04144 | 0.28661146 |
92 | Homologous recombination_Homo sapiens_hsa03440 | 0.26833109 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26254688 |
94 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25818976 |
95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25718478 |
96 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.25683615 |
97 | Mismatch repair_Homo sapiens_hsa03430 | 0.25322544 |
98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25138415 |
99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24119213 |
100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24038928 |
101 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22911174 |
102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22653129 |
103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22485839 |
104 | Adherens junction_Homo sapiens_hsa04520 | 0.22354840 |
105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.22249465 |
106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21727946 |
107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.21180146 |
108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20672864 |
109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20554737 |
110 | Insulin resistance_Homo sapiens_hsa04931 | 0.20108400 |
111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19750929 |
112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19003988 |
113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.18544786 |
114 | Prostate cancer_Homo sapiens_hsa05215 | 0.15261402 |
115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13646472 |
116 | Focal adhesion_Homo sapiens_hsa04510 | 0.11162315 |
117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.11120355 |